NOVELTY – Optimized homopolymer absorbent material comprises 2-5 wt.% of acrylamide monomer and 2-4 wt.% of methylenebisacrylamide as a cross-linking agent. The liquid fuel is selected from hydrocarbons derived from petroleum, biofuels and blends of diesel with biodiesel. USE – Optimized homopolymer absorbent material used for removing free water from emulsified liquid fuels such as hydrocarbons derived from petroleum and biofuels such as blends of diesel and biodiesel. ADVANTAGE – The optimized homopolymer absorbent material provides efficient removal of free water without direct contact with fuel. DESCRIPTION OF DRAWING(S) – The drawing shows a graphical representation depicting monitoring degree of swelling of hydrogel. (Drawing includes non-English language text).
A97 (Miscellaneous goods not specified elsewhere – including papermaking, gramophone records, detergents, food and oil well applications.); E16 (Aliphatics – containing N and/or halogen.); H06 (Gaseous and liquid fuels – including pollution control. Chemical aspects of catalytic exhaust systems for cars are included as well as liquid or gaseous fuels of non-petroleum origin e.g. methanol or ethanol-based fuels. Combustion improvement additives for liquid fuels are included (C10L).); J01 (Separation – including evaporation, crystallisation, solvent extraction, chromatography, dialysis, osmosis including drying gases and/or vapours, and separation of solids from gases, liquids and other solids. Isotope separation, filter materials (including molecular sieves for separation), and centrifuges (except where used for analysis) (B01D, B03, B04, B07B).); A12 (Polymers of di-and higher olefins; acetylenics; nitroso compounds.); A14 (Polymers of other substituted monoolefins; including PVC, PTFE.); J04 (Chemical/physical processes/apparatus – including catalysis, catalysts (excluding specific e.g. enzymatic or polymerisation catalysts), colloid chemistry, laboratory apparatus and methods, testing, controlling, general encapsulation, detection and sampling (excluding clinical testing) (B01J, L).)